3 Results for "

USP28-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "USP28-IN-2" in MCE Product Catalog:

Cat. No.: HY-149228
CAS No.: 2931509-11-2
Target:  

Deubiquitinase

Research Areas:  

Cancer

USP28-IN-2 is a USP28 inhibitor (IC50=0.3 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. USP28-IN-2 shows cytotoxicity against cancer cells, down-regulates the cellular level of c-Myc through ubiquitin-proteasome system. USP28-IN-2 also decreases the ankyrase-1/2 level in vitro. USP28-IN-2 enhance the sensitivity of colorectal cancer cells to Regorafenib (HY-10331) .
loading...
    loading...
Cat. No.: HY-149230
CAS No.: 2931509-15-6
Purity:  99.35%
Target:  

Deubiquitinase

Research Areas:  

Cancer

USP28-IN-4 is a USP28 inhibitor (IC50=0.04 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. USP28-IN-4 shows cytotoxicity against cancer cells, down-regulates the cellular level of c-Myc through ubiquitin-proteasome system. USP28-IN-4 also decreases the ankyrase-1/2 level in vitro. USP28-IN-4 enhance the sensitivity of colorectal cancer cells to Regorafenib (HY-10331) .
loading...
    loading...
Cat. No.: HY-149229
CAS No.: 2931509-14-5
Purity:  98.26%
Target:  

Deubiquitinase

Research Areas:  

Cancer

USP28-IN-3 is a USP28 inhibitor (IC50=0.1 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. USP28-IN-3 shows cytotoxicity against cancer cells, down-regulates the cellular level of c-Myc through ubiquitin-proteasome system. USP28-IN-3 also decreases the ankyrase-1/2 level in vitro. USP28-IN-3 enhance the sensitivity of colorectal cancer cells to Regorafenib (HY-10331) .
loading...
    loading...